Bosnia and Herzegovina vs South Africa: Share of E. coli infections resistant to cephalosporins
Bosnia and Herzegovina
26.8%
in 2022
South Africa
30.0%
in 2022
Bosnia and Herzegovina rank
25th
South Africa rank
24th
Share of E. coli infections resistant to cephalosporins over time
- Bosnia and Herzegovina
- South Africa
How they compare
South Africa currently reports 30.0% against 26.8% in Bosnia and Herzegovina, a difference of 3.2%.
That makes South Africa's figure about 1.1 times Bosnia and Herzegovina's.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was South Africa ahead.
Bosnia and Herzegovina ranks 25th and South Africa ranks 24th of 46 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20.3% | 30.6% | 10.3% | South Africa |
| 2020s | 26.4% | 28.6% | 2.3% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Bosnia and Herzegovina or South Africa?
- South Africa, at 30.0% against 26.8% in Bosnia and Herzegovina as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Bosnia and Herzegovina and South Africa?
- 3.2%, with South Africa ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and South Africa?
- 5 years are reported by both, from 2018 to 2022.
- How do Bosnia and Herzegovina and South Africa rank globally for share of e. coli infections resistant to cephalosporins?
- Bosnia and Herzegovina ranks 25th and South Africa ranks 24th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).